IBM is trading at $245.90 (+3.52%) following a UBS upgrade and a $112 million defense contract.

  • UBS raised its rating from sell to neutral with a $236 price target, providing a positive catalyst for the stock.
  • The company secured a $112 million contract with the Defense Commissary Agency to modernize pricing systems at military commissaries.
  • Shares are rebounding from a sharp 13% decline on February 23, showing strength despite broader market volatility.